LASA SUPERGENERICS
Back to Balance Sheet
|
LASA SUPERGENERICS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹5.32 Cr | ₹2.84 Cr | ₹6.54 Cr | ₹8.41 Cr | ₹11 Cr |
What is the latest Total Non-Current Liabilities ratio of LASA SUPERGENERICS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2024 | ₹5.32 Cr |
| Mar2023 | ₹2.84 Cr |
| Mar2022 | ₹6.54 Cr |
| Mar2021 | ₹8.41 Cr |
| Mar2020 | ₹11 Cr |
How is Total Non-Current Liabilities of LASA SUPERGENERICS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2024 | ₹5.32 Cr | 87.33 | |
| Mar2023 | ₹2.84 Cr | -56.54 | |
| Mar2022 | ₹6.54 Cr | -22.25 | |
| Mar2021 | ₹8.41 Cr | -26.44 | |
| Mar2020 | ₹11 Cr | - | |
Compare Total Non-Current Liabilities of peers of LASA SUPERGENERICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| LASA SUPERGENERICS | ₹46.2 Cr | -1.4% | 0.9% | -63.9% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹382,694.0 Cr | -2.3% | -7.3% | -12.8% | Stock Analytics | |
| DIVIS LABORATORIES | ₹160,721.0 Cr | 0.8% | -5.8% | 4.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹134,016.0 Cr | 0.8% | 3.7% | 20.8% | Stock Analytics | |
| CIPLA | ₹106,946.0 Cr | 0.7% | -11.2% | -6.5% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹101,691.0 Cr | -1.4% | -3.8% | -1.3% | Stock Analytics | |
LASA SUPERGENERICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| LASA SUPERGENERICS | -1.4% |
0.9% |
-63.9% |
| SENSEX | -0.1% |
-2.9% |
7.5% |
You may also like the below Video Courses